R-EPOCH regimen

WikiDoc Resources for R-EPOCH regimen
Articles
Most recent articles on R-EPOCH regimen Most cited articles on R-EPOCH regimen Review articles on R-EPOCH regimen Articles on R-EPOCH regimen in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on R-EPOCH regimen Images of R-EPOCH regimen Photos of R-EPOCH regimen Podcasts & MP3s on R-EPOCH regimen Videos on R-EPOCH regimen
Evidence Based Medicine
Cochrane Collaboration on R-EPOCH regimen Bandolier on R-EPOCH regimen TRIP on R-EPOCH regimen
Clinical Trials
Ongoing Trials on R-EPOCH regimen at Clinical Trials.gov Trial results on R-EPOCH regimen Clinical Trials on R-EPOCH regimen at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on R-EPOCH regimen NICE Guidance on R-EPOCH regimen NHS PRODIGY Guidance FDA on R-EPOCH regimen CDC on R-EPOCH regimen
Books
Books on R-EPOCH regimen
News
R-EPOCH regimen in the news Be alerted to news on R-EPOCH regimen News trends on R-EPOCH regimen
Commentary
Blogs on R-EPOCH regimen
Definitions
Definitions of R-EPOCH regimen
Patient Resources / Community
Patient resources on R-EPOCH regimen Discussion groups on R-EPOCH regimen Patient Handouts on R-EPOCH regimen Directions to Hospitals Treating R-EPOCH regimen Risk calculators and risk factors for R-EPOCH regimen
Healthcare Provider Resources
Symptoms of R-EPOCH regimen Causes & Risk Factors for R-EPOCH regimen Diagnostic studies for R-EPOCH regimen Treatment of R-EPOCH regimen
Continuing Medical Education (CME)
CME Programs on R-EPOCH regimen
International
R-EPOCH regimen en Espanol R-EPOCH regimen en Francais
Business
R-EPOCH regimen in the Marketplace Patents on R-EPOCH regimen
Experimental / Informatics
List of terms related to R-EPOCH regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords:

Overview

R-EPOCH regimen refers to a regimen consisting of xxx used to treat Hodgkin's lymphoma.

Regimen

xxx

xxx

xxx

xxx

Indications

• Hodgkin's lymphoma, nodular lymphocyte-predominant